Testing effectiveness (Phase 2)WithdrawnNCT06365970
What this trial is testing
Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
Who this might be right for
MMR-D/MSI-H Colorectal Cancers
Ibrahim Halil Sahin
Showing 2 of 2 results